172 related articles for article (PubMed ID: 37244948)
21. High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
Niehaus AJ; Mlisana K; Gandhi NR; Mathema B; Brust JC
PLoS One; 2015; 10(9):e0135003. PubMed ID: 26332235
[TBL] [Abstract][Full Text] [Related]
22. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
Silva C; Perdigão J; Jordão L; Portugal I
Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
[TBL] [Abstract][Full Text] [Related]
23. Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa.
Müller B; Chihota VN; Pillay M; Klopper M; Streicher EM; Coetzee G; Trollip A; Hayes C; Bosman ME; Gey van Pittius NC; Victor TC; Gagneux S; van Helden PD; Warren RM
PLoS One; 2013; 8(8):e70919. PubMed ID: 24058399
[TBL] [Abstract][Full Text] [Related]
24. Identification and characterization of potential druggable targets among hypothetical proteins of extensively drug resistant Mycobacterium tuberculosis (XDR KZN 605) through subtractive genomics approach.
Uddin R; Siddiqui QN; Azam SS; Saima B; Wadood A
Eur J Pharm Sci; 2018 Mar; 114():13-23. PubMed ID: 29174549
[TBL] [Abstract][Full Text] [Related]
25. First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda.
Kabahita JM; Kabugo J; Kakooza F; Adam I; Guido O; Byabajungu H; Namutebi J; Namaganda MM; Lutaaya P; Otim J; Kakembo FE; Kanyerezi S; Nabisubi P; Sserwadda I; Kasule GW; Nakato H; Musisi K; Oola D; Joloba ML; Mboowa G
Antimicrob Resist Infect Control; 2022 May; 11(1):68. PubMed ID: 35550202
[TBL] [Abstract][Full Text] [Related]
26. Drug-Resistant Tuberculosis on the Balkan Peninsula: Determination of Drug Resistance Mechanisms with Xpert MTB/XDR and Whole-Genome Sequencing Analysis.
Truden S; Sodja E; Žolnir-Dovč M
Microbiol Spectr; 2023 Mar; 11(2):e0276122. PubMed ID: 36877052
[TBL] [Abstract][Full Text] [Related]
27. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T
J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
[TBL] [Abstract][Full Text] [Related]
28. Clusters of Drug-Resistant Mycobacterium tuberculosis Detected by Whole-Genome Sequence Analysis of Nationwide Sample, Thailand, 2014-2017.
Nonghanphithak D; Chaiprasert A; Smithtikarn S; Kamolwat P; Pungrassami P; Chongsuvivatwong V; Mahasirimongkol S; Reechaipichitkul W; Leepiyasakulchai C; Phelan JE; Blair D; Clark TG; Faksri K
Emerg Infect Dis; 2021 Mar; 27(3):813-822. PubMed ID: 33622486
[TBL] [Abstract][Full Text] [Related]
29. Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update.
Chaiprasert A; Srimuang S; Tingtoy N; Makhao N; Sirirudeeporn P; Tomnongdee N; Theankeaw O; Charoensook S; Leechawengwongs M; Prammananan T
Int J Tuberc Lung Dis; 2014 Aug; 18(8):961-3. PubMed ID: 25199012
[TBL] [Abstract][Full Text] [Related]
30. First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil.
Salvato RS; Costa ERD; Reis AJ; Schiefelbein SH; Halon ML; Barcellos RB; Unis G; Dias CF; Viveiros M; Portugal I; da Silva PEA; Kritski AL; Perdigão J; Rossetti MLR
Infect Genet Evol; 2020 Mar; 78():104127. PubMed ID: 31783187
[TBL] [Abstract][Full Text] [Related]
31. What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis.
Heyckendorf J; Andres S; Köser CU; Olaru ID; Schön T; Sturegård E; Beckert P; Schleusener V; Kohl TA; Hillemann D; Moradigaravand D; Parkhill J; Peacock SJ; Niemann S; Lange C; Merker M
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29133554
[TBL] [Abstract][Full Text] [Related]
32. Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.
Yuan X; Zhang T; Kawakami K; Zhu J; Zheng W; Li H; Deng G; Tu S; Liu W
BMC Infect Dis; 2013 Jul; 13():315. PubMed ID: 23849244
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
Guglielmetti L; Veziris N; Aubry A; Brossier F; Bernard C; Sougakoff W; Jarlier V; Robert J
Int J Tuberc Lung Dis; 2018 Jan; 22(1):54-59. PubMed ID: 29297426
[TBL] [Abstract][Full Text] [Related]
34. Clinical outcomes and molecular characterization of drug-resistant tuberculosis in pre- and extensively drug-resistant disease based on line probe assays.
Araújo LG; Garcia MT; Zaccariotto TR; Moretti ML; Levy CE; Resende MR
Braz J Infect Dis; 2021; 25(1):101544. PubMed ID: 33592172
[TBL] [Abstract][Full Text] [Related]
35. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
[TBL] [Abstract][Full Text] [Related]
36. Mutations of Mycobacterium tuberculosis induced by anti-tuberculosis treatment result in metabolism changes and elevation of ethambutol resistance.
Sun L; Zhang L; Wang T; Jiao W; Li Q; Yin Q; Li J; Qi H; Xu F; Shen C; Xiao J; Liu S; Mokrousov I; Huang H; Shen A
Infect Genet Evol; 2019 Aug; 72():151-158. PubMed ID: 30292007
[TBL] [Abstract][Full Text] [Related]
37. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran.
Velayati AA; Masjedi MR; Farnia P; Tabarsi P; Ghanavi J; ZiaZarifi AH; Hoffner SE
Chest; 2009 Aug; 136(2):420-425. PubMed ID: 19349380
[TBL] [Abstract][Full Text] [Related]
38. 24 loci MIRU-VNTR analysis and pattern of drug resistance in pre-extensively drug resistant pulmonary tuberculosis in Bangladesh.
Monir BB; Sultana SS; Tarafder S
Infect Genet Evol; 2022 Aug; 102():105304. PubMed ID: 35595025
[TBL] [Abstract][Full Text] [Related]
39. Laboratory-based study of drug resistance and genotypic profile of multidrug-resistant tuberculosis isolates in Salvador, Bahia, Brazil.
Sousa EO; Carneiro RTO; Montes FCOF; Conceição EC; Bartholomay P; Marinho JM; Lima KVB; Natividade MSD; Araújo WN; Matos ED; Barbosa T
Rev Soc Bras Med Trop; 2022; 55():e00132022. PubMed ID: 35894395
[TBL] [Abstract][Full Text] [Related]
40. Early detection of multidrug- and pre-extensively drug-resistant tuberculosis from smear-positive sputum by direct sequencing.
Chen J; Peng P; Du Y; Ren Y; Chen L; Rao Y; Wang W
BMC Infect Dis; 2017 Apr; 17(1):300. PubMed ID: 28438132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
